tru4-1

Monoclonal antibodies cannot be used for post-exposure prophylaxis of COVID-19.

Remdesivir is indicated for use in patients with mild-to-moderate disease.

The SARS-CoV-2 viral particle is non-enveloped.

Classic types of vaccines are not applicable in the case of SARS-CoV-2.

Conservative management of symptomatic COVID-19 is based on: